Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes: « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   - « April » « 2025 » M T W T F S S 31 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 1 2 3 4   Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carlsson, Ylva
COPE, NCT04433364: - COVID-19 in Pregnancy and Early Childhood	Active, not recruiting	N/A	3834	Europe	biological samples, questionnaires and interviews	Sahlgrenska University Hospital, Sweden	Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm, Pregnancy in Diabetic, Neonatal Infection	12/26	12/40
IMPACT, NCT03831490: Study for Improving Maternal, Pregnancy and Child Outcomes	Completed	N/A	13000	Europe	history, mean material blod pressure, PlGF - blood sample, a- uterine doppler	Uppsala University, Thermo Fisher Scientific, Inc, Perkin Elmer Inc., Roche Pharma AG	Pre-Eclampsia	12/22	12/22

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Carlsson, Ylva
COPE, NCT04433364: - COVID-19 in Pregnancy and Early Childhood	Active, not recruiting	N/A	3834	Europe	biological samples, questionnaires and interviews	Sahlgrenska University Hospital, Sweden	Sars-CoV2, Covid-19, Pregnancy Complications, Pregnancy Preterm, Pregnancy in Diabetic, Neonatal Infection	12/26	12/40
IMPACT, NCT03831490: Study for Improving Maternal, Pregnancy and Child Outcomes	Completed	N/A	13000	Europe	history, mean material blod pressure, PlGF - blood sample, a- uterine doppler	Uppsala University, Thermo Fisher Scientific, Inc, Perkin Elmer Inc., Roche Pharma AG	Pre-Eclampsia	12/22	12/22